Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV

Werner Meier, Andreas Du Bois, Jörn Rau, Martina Gropp-Meier, Klaus Baumann, Jens Huober, Kerstin Wollschlaeger, Rolf Kreienberg, Ulrich Canzler, Barbara Schmalfeldt, Pauline Wimberger, Barbara Richter, Willibald Schröder, Antje Belau, Anne Stähle, Alexander Burges, Jalid Sehouli

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science